© 2021 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Morningstar Rating ™ as at end of August 2021.
Source: HSBC Institutional Trust Services (Asia) Limited. Download Annual Return Record of funds.
Our portfolio disclosure policy can be obtained from the Investment Manager upon request to email fis@vp.com.hk

Performance shown is NAV to NAV in denominated currency with income reinvested. For funds/classes denominated in foreign currencies, US/HK dollar-based investors are therefore exposed to fluctuations in the currency exchange rate.

#Value Partners Health Care Fund is a sub-fund of Value Partners Ireland Fund ICAV (the “Company”). The Company is both authorized and supervised by the Central Bank of Ireland (“Central Bank”) as an undertaking for collective investment in transferable securities pursuant to the European Communities (Undertakings for Collective Investment in Transferable Securities) Regulations 2011. Authorization of the Company by the Central Bank shall not constitute a warranty as to the performance of the Company and the Central Bank shall not be liable or the performance or default of the Company. The authorization of the Company is not an endorsement or guarantee of the Company by the Central Bank.
*Investors should note that the base currency of “C” Units is in USD. The HKD is for reference only and should not be used for subscription or redemption purpose. Conversion to the base currency of “C” Units will normally take place at the prevailing rate (as determined by the Fund’s Trustee or Custodian) on the corresponding fund dealing day. Investor should be aware of possible risks resulting from fluctuations of exchange rates against USD.
^Investors should note that the base currency of the Fund is in USD. The HKD equivalent NAV per unit is for reference only and should not be used for subscription or redemption purpose. Conversion to the base currency of the Fund will normally take place at the prevailing rate (as determined by the Fund’s Trustee or Custodian) on the corresponding fund dealing day. Investors should be aware of possible risks resulting from fluctuations of exchange rates against USD.

Funds can be highly illiquid and are not suitable for all investors. The website is not an endorsement of a fund’s suitability for any particular investor or class of investors.
Investment involves risk. The price of units may go down as well as up and past performance is not indicative of future results. Investors may not get back the full amount invested. Please refer to the explanatory memorandum. The website has not been reviewed by the Securities and Futures Commission. Issuer: Value Partners Hong Kong Limited/Value Partners Limited.